Healthway Medical Corporation Limited announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2015. For the period, the company reported revenue of SGD 94,273,000 against SGD 85,666,000 a year ago. The increase was mainly due to the increase in revenue of SGD 4.4 million from the Primary Healthcare segment and SGD 4.2 million from the Specialist & Wellness Healthcare segment. The increase in revenue was mainly due to increase in patient load for both segments. Profit before income tax was SGD 2,696,000 against SGD 9,933,000 a year ago. Profit attributable to equity holders of the company was SGD 1,683,000 or 0.07 cents per basic and diluted share against SGD 9,840,000 or 0.43 cents per basic and diluted share a year ago. Net cash provided by operating activities was SGD 3,873,000 against SGD 8,856,000 a year ago. Purchase of property, plant and equipment was SGD 1,300,000 against SGD 1,943,000 a year ago. Net asset value per share as at December 31, 2015 was 8.31 cents against 8.26 cents a year ago. EBITDA was SGD 2,876,000 against LBITDA of SGD 2,049,000 a year ago.

For the quarter, the company reported revenue of SGD 23,328,000 against SGD 21,260,000 a year ago. Loss before income tax was SGD 1,229,000 against SGD 3,396,000 a year ago. Loss attributable to equity holders of the company was SGD 904,000 or 0.05 cents per basic and diluted share against SGD 2,824,000 or 0.12 cents per basic and diluted share a year ago. Net cash provided by operating activities was SGD 1,137,000 against SGD 999,000 a year ago. Purchase of property, plant and equipment was SGD 343,000 against SGD 1,456,000 a year ago.